LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 25.92 | 21.74 | 17 | 1515 | 0.0112 | -0.0394 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 25.92 | 21.74 | 1232 | 1515 | 0.8129 | 0.9335 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 25.92 | 21.74 | 2 | 1515 | 0.0013 | -0.3227 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 25.92 | 21.74 | 1242 | 1515 | 0.8195 | 0.9360 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 27.89 | 21.74 | 28 | 1677 | 0.0167 | 0.0412 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 27.89 | 21.74 | 1314 | 1677 | 0.7835 | 0.9237 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 27.89 | 21.74 | 1 | 1677 | 0.0006 | -0.3881 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 27.89 | 21.74 | 1281 | 1677 | 0.7639 | 0.9159 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 29.86 | 21.74 | 22 | 1887 | 0.0117 | 0.0019 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 29.86 | 21.74 | 1399 | 1887 | 0.7414 | 0.9092 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 29.86 | 21.74 | 1 | 1887 | 0.0005 | -0.3801 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 29.86 | 21.74 | 1364 | 1887 | 0.7228 | 0.9017 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 31.83 | 21.74 | 47 | 2110 | 0.0223 | 0.1239 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 31.83 | 21.74 | 1468 | 2110 | 0.6957 | 0.8930 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 31.83 | 21.74 | 1 | 2110 | 0.0005 | -0.3728 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 31.83 | 21.74 | 1417 | 2110 | 0.6716 | 0.8829 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 33.80 | 21.74 | 43 | 2381 | 0.0181 | 0.1059 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 33.80 | 21.74 | 1536 | 2381 | 0.6450 | 0.8747 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 33.80 | 21.74 | 6 | 2381 | 0.0025 | -0.1731 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 33.80 | 21.74 | 1541 | 2381 | 0.6471 | 0.8756 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 35.77 | 21.74 | 52 | 2602 | 0.0200 | 0.1347 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 35.77 | 21.74 | 1630 | 2602 | 0.6262 | 0.8689 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 35.77 | 21.74 | 7 | 2602 | 0.0027 | -0.1514 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 35.77 | 21.74 | 1617 | 2602 | 0.6212 | 0.8667 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 37.74 | 21.74 | 58 | 2828 | 0.0205 | 0.1500 | MN20160310_N01 | J22 |